LEADING THE WAY IN CANCER RESEARCH

Tennessee Cancer Specialists is an established cancer research leader in communities across the East Tennessee region. We offer clinical trials through Sarah Cannon Research Institute (SCRI), one of the world’s leading oncology research organizations conducting clinical trials in the community. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the U.S. Food and Drug Administration (FDA) in the past decade.

Our cancer research program, SCRI at Tennessee Cancer Specialists, provides access to the latest clinical trials to people with cancer. Our program is part of an expansive research network with the goals of advancing therapies for patients and transforming cancer care within their own community, where the majority of people with cancer seek treatment.

To learn more about clinical trials available at Tennessee Cancer Specialists, call 865-862-0998, select option 3 or explore open clinical trials through our clinical trial search tool.